• Lekshmi S. Department of Pharmacy, FEAT, Annamalai University, Chidambaram,Tamil Nadu, India
  • G. P. Mohanta Department of Pharmacy, FEAT, Annamalai University, Chidambaram, Tamil Nadu, India
  • K. G. Revikumar Director Research, Alshifa College of pharmacy, Kizhattur. Perinthalmanna, Malappuram, Kerala, India
  • P. K. Manna Department of Pharmacy, FEAT, Annamalai University, Chidambaram, Tamil Nadu, India


Hypertension, Medicine Price, Karunya Community Pharmacy, Public sector


Objective: Since the 1970s, one of the smallest Indian States, Kerala, has been internationally applauded for its excellent performance in its health indicators. Even if mortality is low, the morbidity (those suffering from chronic/non-communicable diseases) levels in urban and rural is high in Kerala compared to other Indian states. Gradually, the public sector becomes incapable to convene the demands for health care and people have responded to this meagerness by increasing the use of an emerging private sector. To overcome this scenario, Kerala government established KMSCL for promoting access to medicines to the patients approaching the public hospitals in Kerala by making available selected essential medicines at free of cost. The present study was conducted to evaluate the availability, cost and affordability of anti-hypertensive medicines in Kerala.

Methods: This prospective, observational study was conducted in Trivandrum district in Kerala, from June 2013 to November 2013. Three types of medication prices were taken into contemplation with the intension for calculation purposes, the highest and the lowest branded medication costs in private pharmacy and Karunya Community Pharmacy (KCP) prices. Affordability was calculated for the different level of skilled workers and through the wages fixed by the government of Kerala for these categories, who were consuming the medications at the time. A comparison was also done between various treatment guidelines of hypertension.

Results: There was 15.5% to 230% price variation between the highest and lowest price of branded anti-hypertensive medicines respectively. For treating Stage 3 of hypertension; unskilled and highly skilled workers had to spend a minimum of 1.22 and 0.84 wage days respectively and a maximum of 5.23 and 4.34 wage days respectively in private pharmacies. All the medicines required for the treatments of hypertension were available in both private and KCP.

Conclusion: The study revealed that there was an average availability at of antihypertensive medicines in public health facilities. The availability of all medicines at KCP in low price shows the good impact of KMSCL for promoting access of medicines to the poor.


Download data is not yet available.


Medicine Prices and Affordability-A Policy Brief on Drug Pricing. All India Drug Action Network (AIDAN) A Campaign Group for Rational Drug Therapy and Policy! 2009 March. Available from: URL:

Usha R, J Vandana, Arun Kumar Agarwal. Cost of medicines & their affordability in private pharmacies in Delhi (India). Indian Res 2012;136:827-35.

CBM Kotwani. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all. Ser Res 2013;13:285.

Samit Sharma MD, IAS. Making Medicines Affordable. Low cost Generic Drugs Initiative in Rajasthan. Available from: URL:

National Rural Health Mission (NRHM ,Program Implementation Plan, Kerala; 2012. p. 415.

K Kerala, S Bipin. World Health Day and Kerala vol. 2013;33(6):30-1.

Hypertension guidelines, The Association of Physicians of India (API). Available from: URL: http:// hsi_guideline_ii.html#hsi_guideline_ii

Treatment protocol of hypertension by government of Kerala (Directorate of Health Services). Available from: URL:

Census report of 2011. Available from: URL:

Kerala: Revised Minimum Wages. March 5, 2011. Gazette notification of Labour Ministry, Government of Kerala, 2011. Available from: URL:

Veena R, Revikumar KG, Manna PK, Mohanta GP. Emerging trends in medicine procurement in government sector in India-A critical study. Int J Res Pharm Sci 2010;1(3):372-81,

Gangadharan K. Policy reforms and healthcare system in Kerala. Journal of Health and Development; 2008;4:1.

Vandana Roy, Usha Gupta, Arun Kumar Agarwal. Cost of medicines & their affordability in private pharmacies in Delhi (India). Indian J Med Res 2012;136:827-35.

Akram Ahmad, Isha Patel, Sudeepa Sanyal, R Balkrishnan, GP Mohanta. Availability, Cost and affordability of antimalarial medicines in india IJPCR 2014;6(1):7-12.

Lekshmi S, GP Mohanta, KG Revikumar, PK Manna. Developments And emerging issues in public and private health care systems of kerala. Int J Pharm Pharm Sci 2014;6 Suppl 2:92-8.

NRHM guidelines for Hypertension. Available from: URL:

Guideline for Management of High Blood Pressure, JNC 8 Guidelines. 2014. Available from: URL: http:// [Accessed on 12/19/2013].



How to Cite

S., L., G. P. Mohanta, K. G. Revikumar, and P. K. Manna. “STUDY ON AVAILABILITY AND AFFORDABILITY OF ANTI HYPERTENSIVE MEDICINES IN THE STATE OF KERALA”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 10, Oct. 2014, pp. 364-9,



Original Article(s)